Our Focus on Value for Patients

At Vertex, we are relentless in our pursuit to create transformative medicines. We have spent the last 20 years doing what was once thought impossible — developing the first medicines that treat the underlying cause of CF.  The price of our medicines reflects the significant value they bring to patients and our commitment to continuing to invest in the development of new medicines for those still waiting.

Our Approach
Vertex by the Numbers
Vertex by the numbers
Vertex by the Numbers Percentage Invested in R&D in 2019
Vertex by the numbers
*Operating expenses are defined as R&D + Sales General & Administrative. All figures are calculated using GAAP.